Smart pen study shows promise for diabetes control
NCT ID NCT05069545
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 22 times
Summary
This study looked at whether using a smart insulin pen (NovoPen 6) with two insulins (Tresiba and Fiasp) helps people with type 1 diabetes achieve better blood sugar levels. Over 400 adults took part for about 9-11 months, using the pen to track doses and a mobile app to see their glucose data. The main goal was to see if the percentage of time blood sugar stayed in a healthy range improved.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 1 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Aarhus Universitetshospital Diabetes og Hormonsygdomme
Aarhus N, 8200, Denmark
-
Ap-Hp-Hopital Bichat-Claude Bernard-1
Paris, 75877, France
-
Bispebjerg Hospital, IC-Forskning
Copenhagen, 2400, Denmark
-
Centre Hospitalier Sud Francilien
Corbeil-Essonnes, 91106, France
-
Centre Hospitalier Universitaire de Caen Normandie- Cote de Nacre
Caen, 14033, France
-
Centre Hospitalier Universitaire de Liège
Liège, 4000, Belgium
-
Centre Hospitalier Universitaire de Montpellier-Hopital Lapeyronie
Montpellier, 34295, France
-
Centre Hospitalier Universitaire de Toulouse-Hopital Rangueil-2
Toulouse, 31054, France
-
Centrum for Diabetes, Academical Specialist Centrum
Stockholm, 113 65, Sweden
-
Chru de Nancy - Hopital Brabois
Vandœuvre-lès-Nancy, 54511, France
-
Cliniques Universitaires Saint-Luc - Serv Endocrinologie - Diabétologie
Brussels, 1200, Belgium
-
Diabetesmottagningen, Medicinkliniken, Södra Älvsborgs Sjukhus
Borås, 501 82, Sweden
-
Diabetesmottagningen, Södra Älvsborgs Sjukhus
Borås, 501 82, Sweden
-
Endokrinologiska kliniken, Malmö
Malmö, 205 02, Sweden
-
Frölunda Specialistsjukhus
Västra Frölunda, 42144, Sweden
-
HUB - Hôpital Erasme
Brussels, 1070, Belgium
-
Hospices Civils de Lyon-Hopital Lyon Sud-2
Pierre-Bénite, 69495, France
-
Imeldaziekenhuis - Bonheiden - Department of Endocrinology
Bonheiden, 2820, Belgium
-
Medicinkliniken Sundsv
Sundsvall, 851 86, Sweden
-
Medicinmottagning1 Universitetssjukhuset Örebro
Örebro, 701 85, Sweden
-
Medicinsk Afdeling B, Herning Centralsygehus
Herning, 7400, Denmark
-
Regionshospitalet Silkeborg - Endokrinologisk afd.
Silkeborg, 8600, Denmark
-
UZ Leuven - Endocrinology
Leuven, 3000, Belgium
-
UZA - UZ Antwerpen - Department of Endocrinology
Edegem, 2650, Belgium
-
Uppsala universitetssjukhus
Uppsala, 751 85, Sweden
-
hôpital Saint Joseph Saint Luc
Lyon, 69365, France
Conditions
Explore the condition pages connected to this study.